Entry - #270960 - SPERMATOGENIC FAILURE 4; SPGF4 - OMIM

# 270960

SPERMATOGENIC FAILURE 4; SPGF4


Alternative titles; symbols

AZOOSPERMIA DUE TO PERTURBATIONS OF MEIOSIS
AZOOSPERMIA WITH MATURATION ARREST
SPERMATOGENESIS ARREST


Other entities represented in this entry:

PREGNANCY LOSS, RECURRENT, 4, INCLUDED; RPRGL4, INCLUDED

Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
12q23.2 Pregnancy loss, recurrent, 4 270960 AD 3 SYCP3 604759
12q23.2 Spermatogenic failure 4 270960 AD 3 SYCP3 604759
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal dominant
GENITOURINARY
Internal Genitalia (Male)
- Azoospermia
- Testicular histology shows arrest of spermatogenesis at the pachytene stage of primary spermatocytes
Internal Genitalia (Female)
- Spontaneous abortion, recurrent
- Fetal loss after 6 to 10 weeks of gestation
MISCELLANEOUS
- Affected males are infertile, whereas affected females have recurrent pregnancy loss
MOLECULAR BASIS
- Caused by mutation in the synaptonemal complex protein-3 gene (SYCP3, 604759.0001)
Spermatogenic failure - PS258150 - 104 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p34.3 ?Spermatogenic failure 83 AR 3 620354 DNALI1 602135
1p31.1 Spermatogenic failure 2 AR 3 108420 MSH4 602105
1p22.1 ?Spermatogenic failure 21 AR 3 617644 BRDT 602144
1p12 ?Spermatogenic failure 55 AR 3 619380 SPAG17 616554
2p23.3 Spermatogenic failure 80 AR 3 620222 DRC1 615288
2p13.1 Spermatogenic failure 48 AR 3 619108 M1AP 619098
2q11.2 ?Spermatogenic failure 26 AR 3 617961 TSGA10 607166
2q32.1 Spermatogenic failure 34 AR 3 618153 FSIP2 615796
2q33.1 ?Spermatogenic failure 68 AR 3 619805 C2CD6 619776
2q35 ?Spermatogenic failure 54 AR 3 619379 CATIP 619387
2q35 Spermatogenic failure 40 AR 3 618664 CFAP65 614270
3p22.2 Spermatogenic failure 37 AR 3 618429 TTC21A 611430
3p21.1 Spermatogenic failure 18 AR 3 617576 DNAH1 603332
3q13.2 Spermatogenic failure 20 AR 3 617593 CFAP44 617559
3q13.33 Spermatogenic failure 51 AR 3 619177 CFAP91 609910
3q26.31 ?Spermatogenic failure 6 AR 3 102530 SPATA16 609856
4p16.3 ?Spermatogenic failure 62 AR 3 619673 RNF212 612041
4p14 ?Spermatogenic failure 72 AR 3 619867 WDR19 608151
4q12 ?Spermatogenic failure 29 AR 3 618091 SPINK2 605753
4q22.3 Spermatogenic failure 70 AR 3 619828 PDHA2 179061
4q31.22 Spermatogenic failure 42 AR 3 618745 TTC29 618735
5p13.2 Spermatogenic failure 43 AR 3 618751 SPEF2 610172
6p21.33 Spermatogenic failure 74 AR 3 619937 MSH5 603382
6p21.31 Spermatogenic failure 90 AR 3 620744 ARMC12 620377
6p21.31 Spermatogenic failure 3 AD, AR 3 606766 SLC26A8 608480
6p21.2 Spermatogenic failure 46 AR 3 619095 DNAH8 603337
6q15 ?Spermatogenic failure 85 AR 3 620490 SPACA1 612739
6q21 Spermatogenic failure 38 AR 3 618433 ARMC2 618424
6q21 Spermatogenic failure 89 AR 3 620705 AK9 615358
6q25.3 Spermatogenic failure 57 AR 3 619528 PNLDC1 619529
7p12.2 ?Spermatogenic failure 66 AR 3 619799 ZPBP 608498
7q11.23 Spermatogenic failure 77 AR 3 620103 FKBP6 604839
7q21.13 Spermatogenic failure 24 AR 3 617959 CFAP69 617949
7q22.1 Spermatogenic failure 61 AR 3 619672 STAG3 608489
7q36.1 Spermatogenic failure 50 AR 3 619145 XRCC2 600375
8p12 Spermatogenic failure 25 AR 3 617960 TEX15 605795
8p11.23 Spermatogenic failure 79 AR 3 620196 KCNU1 615215
8q22.2 Spermatogenic failure 64 AR 3 619696 FBXO43 609110
9p21.2 Spermatogenic failure 58 AR 3 619585 IFT74 608040
9p13.3 Spermatogenic failure 91 AR 3 620838 CCIN 603960
9q31.3 Spermatogenic failure 86 AR 3 620499 ACTL7A 604303
9q31.3 Spermatogenic failure 75 AR 3 619949 SHOC1 618038
9q33.3 Spermatogenic failure 8 AD 3 613957 NR5A1 184757
9q34.3 Spermatogenic failure 32 AD 3 618115 SOHLH1 610224
10q22.2 ?Spermatogenic failure 41 AR 3 618670 CFAP70 618661
10q25.1 Spermatogenic failure 19 AR 3 617592 CFAP43 617558
10q25.1 Spermatogenic failure 49 AR 3 619144 CFAP58 619129
10q26.11 Spermatogenic failure 12 AD 3 615413 NANOS1 608226
10q26.3 ?Spermatogenic failure 15 AR 3 616950 SYCE1 611486
11p15.4 Spermatogenic failure 65 AR 3 619712 DHND1 617277
11p15.4 ?Spermatogenic failure 93 3 620849 STK33 607670
11p14.1 Spermatogenic failure 76 AR 3 620084 CCDC34 612324
11q13.1 Spermatogenic failure 7 AR 3 612997 CATSPER1 606389
12p13.32 Spermatogenic failure 82 AR 3 620353 AKAP3 604689
12p13.31 Spermatogenic failure 92 AR 3 620848 LRRC23 620708
12p12.3 Spermatogenic failure 17 AR 3 617214 PLCZ1 608075
12q14.2 Spermatogenic failure 9 AR 3 613958 DPY19L2 613893
12q23.2 Pregnancy loss, recurrent, 4 AD 3 270960 SYCP3 604759
12q23.2 Spermatogenic failure 4 AD 3 270960 SYCP3 604759
12q24.31 Spermatogenic failure 33 AR 3 618152 WDR66 618146
12q24.31 ?Spermatogenic failure 67 AR 3 619803 CCDC62 613481
12q24.31 Spermatogenic failure 56 AR 3 619515 DNAH10 605884
13q32.1 Spermatogenic failure 47 AR 3 619102 DZIP1 608671
14q13.2 Spermatogenic failure 36 AD 3 618420 PPP2R3C 615902
14q21.2 Spermatogenic failure 28 AR 3 618086 FANCM 609644
14q21.2 ?Spermatogenic failure 63 AR 3 619689 RPL10L 619655
14q23.1 Spermatogenic failure 52 AR 3 619202 C14orf39 617307
14q32.2 ?Spermatogenic failure 27 AR 3 617965 AK7 615364
14q32.33 ?Spermatogenic failure 30 AR 3 618110 TDRD9 617963
15q21.1 ?Spermatogenic failure 59 AR 3 619645 TERB2 617131
16p13.3 Spermatogenic failure 22 AR 3 617706 MEIOB 617670
16p13.3 Spermatogenic failure 10 AD 3 614822 SEPT12 611562
16q22.1 Spermatogenic failure 60 AR 3 619646 TERB1 617332
16q22.2 Spermatogenic failure 31 AR 3 618112 PMFBP1 618085
17p13.2 ?Spermatogenic failure 14 AR 3 615842 ZMYND15 614312
17p13.1 Spermatogenic failure 45 AR 3 619094 DNAH2 603333
17p12 Spermatogenic failure 81 AR 3 620277 TEKT3 612683
17p12 Spermatogenic failure 71 AR 3 619831 ZSWIM7 614535
17q21.2 Spermatogenic failure 11 AD 3 615081 KLHL10 608778
17q22 Spermatogenic failure 23 AR 3 617707 TEX14 605792
17q24.1 Spermatogenic failure 44 AR 3 619044 CEP112 618980
17q25.1 Spermatogenic failure 35 AR 3 618341 QRICH2 618304
17q25.3 Spermatogenic failure 39 AR 3 618643 DNAH17 610063
18q11.2 ?Spermatogenic failure 13 AR 3 615841 TAF4B 601689
19p13.2 Spermatogenic failure 53 AR 3 619258 ACTL9 619251
19p13.11 Spermatogenic failure 78 AR 3 620170 IQCN 620160
19q13.2 Spermatogenic failure 69 AR 3 619826 GGN 609966
19q13.33 Spermatogenic failure 88 AR 3 620547 KASH5 618125
19q13.43 Spermatogenic failure 5 AR 3 243060 AURKC 603495
20p11.23 Spermatogenic failure 84 AR 3 620409 CFAP61 620381
20q11.21 Spermatogenic failure 16 AR 3 617187 SUN5 613942
20q13.33 Spermatogenic failure 1 AD 3 258150 SYCP2 604105
22q13.33 ?Spermatogenic failure 73 AR 3 619878 MOV10L1 605794
22q13.33 ?Spermatogenic failure 87 AR 3 620500 ACR 102480
Xp21.1 Spermatogenic failure, X-linked 3 XLR 3 301059 CFAP47 301057
Xp11.23 Spermatogenic failure, X-linked, 5 XL 3 301099 SSX1 312820
Xq13.1 Spermatogenic failure, X-linked 2 XLR 3 309120 TEX11 300311
Xq13.1 Spermatogenic failure, X-linked, 4 XL 3 301077 GCNA 300369
Xq21.1 Spermatogenic failure, X-linked, 8 XL 3 301119 CYLC1 300768
Xq26.2 Spermatogenic failure, X-linked, 6 XL 3 301101 USP26 300309
Xq26.3 ?Spermatogenic failure, X-linked, 7 XLR 3 301106 CT55 301105
Yq11 Spermatogenic failure, Y-linked, 1 YL 4 400042 DELYq11 400042
Yq11.221 Spermatogenic failure, Y-linked, 2 YL 3 415000 USP9Y 400005
Not Mapped Spermatogenic failure, X-linked 1 XL 305700 SPGFX1 305700

TEXT

A number sign (#) is used with this entry because of evidence that spermatogenic failure-4 (SPGF4) and recurrent pregnancy loss (RPRGL4) are caused by heterozygous mutation in the SYCP3 gene (604759) on chromosome 12q23.


Description

Azoospermia, a condition in which there are no sperm present in the ejaculate, has historically been divided into 2 broad categories, obstructive (e.g., 277180) and nonobstructive. Among the genetically based, inherited nonobstructive causes are defects of spermatogenesis, which may interrupt the development of the sperm at various stages, either before (e.g., 415000) or during meiosis. SPGF4 is a form of azoospermia due to perturbations of meiosis.

For a discussion of phenotypic and genetic heterogeneity of spermatogenic failure, see SPGF1 (258150).

Recurrent Pregnancy Loss

Miscarriage, the commonest complication of pregnancy, is the spontaneous loss of a pregnancy before the fetus has reached viability. The term therefore includes all pregnancy losses from the time of conception until 24 weeks' gestation. Recurrent miscarriage, defined as 3 or more consecutive pregnancy losses, affects about 1% of couples; when defined as 2 or more losses, the scale of the problem increases to 5% of all couples trying to conceive (summary by Rai and Regan, 2006).

Pregnancy losses have traditionally been designated 'spontaneous abortions' if they occur before 20 weeks' gestation and 'stillbirths' if they occur after 20 weeks. Subtypes of spontaneous abortions can be further distinguished on the basis of embryonic development and include anembryonic loss in the first 5 weeks after conception (so-called 'blighted ovum'), embryonic loss from 6 to 9 weeks' gestation, and fetal loss from 10 weeks' gestation through the remainder of the pregnancy. These distinctions are important because the causes of pregnancy loss vary over gestational ages, with anembryonic losses being more likely to be associated with chromosomal abnormalities, for example. Possible etiologies for recurrent pregnancy loss include uterine anatomic abnormalities, cytogenetic abnormalities in the parents or fetus, single gene disorders, thrombophilic conditions, and immunologic or endocrine factors as well as environmental or infectious agents (summary by Warren and Silver, 2008).

For a discussion of genetic heterogeneity of recurrent pregnancy loss, see RPRGL1 (614389).


Clinical Features

Chaganti and German (1979) reported a family in which infertility due to azoospermia or oligospermia affected 3 men related through their mothers. Testicular tissue obtained from the 46,XY phenotypically male but azoospermic propositus exhibited normal zygotene and pachytene pairing but premature desynapsis, with a reduced chiasma frequency and degeneration of spermatocytes during the first meiotic division. They postulated that a gene for meiotic disturbance, spermatogenic arrest, and azoospermia was segregating in this family, inherited in either an X-linked recessive or sex-limited autosomal dominant fashion.

Soderstrom and Suominen (1980) examined testicular biopsy specimens from 147 men with the clinical diagnosis of azoospermia or oligospermia. Meiotic arrest was found in 27 cases; closer scrutiny of 7 of the specimens showed that the pattern of meiotic arrest commonly varied in the same specimen, with coexisting areas of normal spermatogenesis and meiotic arrest. Because the timing of the arrest was consistently in the late pachytene stage, with condensation of chromatin along the synaptonemal complex, Soderstrom and Suominen (1980) concluded that there might be a genetic cause for the meiotic arrest.

Chaganti et al. (1980) reported 2 nearly azoospermic sibs of a consanguineous marriage; meiotic cells from a testicular biopsy of the 46,XY phenotypically male proband exhibited asynapsis, defective synaptonemal complex formation, chiasma failure, and degeneration of prophase spermatocytes with asynapsis. The meiotic abnormalities and infertility in this family appeared to comprise an autosomal recessive trait.

Cantu et al. (1981) studied three 46,XY phenotypically male, azoospermic brothers in a sibship of 13 from a consanguineous marriage and found a unique pattern of testicular histology with arrest of spermatogenesis at the pachytene stage of primary spermatocytes.

Recurrent Pregnancy Loss 4

Bolor et al. (2009) studied 2 Japanese women, aged 39 and 29 years, with recurrent pregnancy loss. Each had experienced 3 miscarriages between 6 and 10 weeks of gestation, with no liveborns.


Molecular Genetics

Miyamoto et al. (2003) screened for mutations in the SYCP3 (604759) gene in DNA from 19 unrelated azoospermic patients with maturation arrest and 75 normal pregnancy-proven fertile men. In 2 patients they identified a heterozygous 1-bp deletion (643delA; 604759.0001) that resulted in truncation of the C-terminal, coiled-coil-forming region of the protein. The mutant protein showed greatly reduced interaction with the wildtype protein in vitro and interfered with SYCP3 fiber formation in cultured cells. The results suggested that SYCP3 has an essential meiotic function in human spermatogenesis that is compromised by the mutant protein by dominant-negative interference.

Susceptibility to Recurrent Pregnancy Loss

Bolor et al. (2009) analyzed the SYCP3 gene in 26 Japanese women with recurrent pregnancy loss (RPRGL) and identified heterozygosity for a deletion and a point mutation in 2 of the women (604759.0002 and 604759.0003, respectively) that were not found in 150 fertile women. Both mutant proteins were shown to inhibit normal fiber formation of SYCP3 when coexpressed in a heterologous system. This suggested that the heterozygous mutations are likely to form aberrant lateral elements in the synaptonemal complex in a dominant-negative manner, possibly leading to abnormal chromosomal behavior in meiosis I during oogenesis. Bolor et al. (2009) noted that the SYCP3-related phenotype in humans, in which affected males are infertile whereas affected females have recurrent pregnancy loss, is similar to that seen in Sycp3-deficient mice (Yuan et al., 2000; Yuan et al., 2002).


REFERENCES

  1. Bolor, H., Mori, T., Nishiyama, S., Ito, Y., Hosoba, E., Inagaki, H., Kogo, H., Ohye, T., Tsutsumi, M., Kato, T., Tong, M., Nishizawa, H., Pryor-Koishi, K., Kitaoka, E., Sawada, T., Nishiyama, Y., Udagawa, Y., Kurahashi, H. Mutations of the SYCP3 gene in women with recurrent pregnancy loss. Am. J. Hum. Genet. 84: 14-20, 2009. [PubMed: 19110213, images, related citations] [Full Text]

  2. Cantu, J. M., Rivas, F., Hernandez-Jauregui, P., Diaz, M., Cortes-Gallegos, V., Vaca, G., Velazquez, A., Ibarra, B. Meiotic arrest at first spermatocyte level: a new inherited infertility disorder. Hum. Genet. 59: 380-385, 1981. [PubMed: 6800930, related citations] [Full Text]

  3. Chaganti, R. S. K., German, J. Human male fertility, probably genetically determined, due to defective meiosis and spermatogenic arrest. Am. J. Hum. Genet. 31: 634-641, 1979. [PubMed: 574357, related citations]

  4. Chaganti, R. S. K., Jhanwar, S. C., Ehrenbard, L. T., Kourides, I. A., Williams, J. J. Genetically determined asynapsis, spermatogenic degeneration, and infertility in men. Am. J. Hum. Genet. 32: 833-848, 1980. [PubMed: 7446525, related citations]

  5. Miyamoto, T., Hasuike, S., Yogev, L., Maduro, M. R., Ishikawa, M., Westphal, H., Lamb, D. J. Azoospermia in patients heterozygous for a mutation in SYCP3. Lancet 362: 1714-1719, 2003. [PubMed: 14643120, related citations] [Full Text]

  6. Rai, R., Regan, L. Recurrent miscarriage. Lancet 368: 601-611, 2006. [PubMed: 16905025, related citations] [Full Text]

  7. Soderstrom, K.-O., Suominen, J. Histopathology and ultrastructure of meiotic arrest in human spermatogenesis. Arch. Path. Lab. Med. 104: 476-482, 1980. [PubMed: 6893401, related citations]

  8. Warren, J. E., Silver, R. M. Genetics of pregnancy loss. Clin. Obstet. Gynec. 51: 84-95, 2008. [PubMed: 18303502, related citations] [Full Text]

  9. Yuan, L., Liu, J.-G., Hoja, M.-R., Wilbertz, J., Nordqvist, K., Hoog, C. Female germ cell aneuploidy and embryo death in mice lacking the meiosis-specific protein SCP3. Science 296: 1115-1118, 2002. [PubMed: 12004129, related citations] [Full Text]

  10. Yuan, L., Liu, J.-G., Zhao, J., Brundell, E., Daneholt, B., Hoog, C. The murine SCP3 gene is required for synaptonemal complex assembly, chromosome synapsis, and male fertility. Molec. Cell 5: 73-83, 2000. [PubMed: 10678170, related citations] [Full Text]


Marla J. F. O'Neill - updated : 2/12/2016
Marla J. F. O'Neill - updated : 12/15/2011
Marla J. F. O'Neill - updated : 5/11/2011
John A. Phillips, III - updated : 8/2/2005
Marla J. F. O'Neill - updated : 3/10/2004
Creation Date:
Victor A. McKusick : 6/4/1986
alopez : 06/04/2024
carol : 08/30/2017
carol : 05/12/2016
carol : 2/12/2016
alopez : 12/16/2011
terry : 12/15/2011
terry : 12/9/2011
carol : 5/11/2011
terry : 9/9/2010
alopez : 8/2/2005
carol : 12/14/2004
carol : 3/10/2004
mimadm : 3/12/1994
supermim : 3/17/1992
supermim : 3/20/1990
ddp : 10/27/1989
marie : 3/25/1988
reenie : 6/4/1986

# 270960

SPERMATOGENIC FAILURE 4; SPGF4


Alternative titles; symbols

AZOOSPERMIA DUE TO PERTURBATIONS OF MEIOSIS
AZOOSPERMIA WITH MATURATION ARREST
SPERMATOGENESIS ARREST


Other entities represented in this entry:

PREGNANCY LOSS, RECURRENT, 4, INCLUDED; RPRGL4, INCLUDED

SNOMEDCT: 85716005;   ORPHA: 399805;   DO: 0070176;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
12q23.2 Pregnancy loss, recurrent, 4 270960 Autosomal dominant 3 SYCP3 604759
12q23.2 Spermatogenic failure 4 270960 Autosomal dominant 3 SYCP3 604759

TEXT

A number sign (#) is used with this entry because of evidence that spermatogenic failure-4 (SPGF4) and recurrent pregnancy loss (RPRGL4) are caused by heterozygous mutation in the SYCP3 gene (604759) on chromosome 12q23.


Description

Azoospermia, a condition in which there are no sperm present in the ejaculate, has historically been divided into 2 broad categories, obstructive (e.g., 277180) and nonobstructive. Among the genetically based, inherited nonobstructive causes are defects of spermatogenesis, which may interrupt the development of the sperm at various stages, either before (e.g., 415000) or during meiosis. SPGF4 is a form of azoospermia due to perturbations of meiosis.

For a discussion of phenotypic and genetic heterogeneity of spermatogenic failure, see SPGF1 (258150).

Recurrent Pregnancy Loss

Miscarriage, the commonest complication of pregnancy, is the spontaneous loss of a pregnancy before the fetus has reached viability. The term therefore includes all pregnancy losses from the time of conception until 24 weeks' gestation. Recurrent miscarriage, defined as 3 or more consecutive pregnancy losses, affects about 1% of couples; when defined as 2 or more losses, the scale of the problem increases to 5% of all couples trying to conceive (summary by Rai and Regan, 2006).

Pregnancy losses have traditionally been designated 'spontaneous abortions' if they occur before 20 weeks' gestation and 'stillbirths' if they occur after 20 weeks. Subtypes of spontaneous abortions can be further distinguished on the basis of embryonic development and include anembryonic loss in the first 5 weeks after conception (so-called 'blighted ovum'), embryonic loss from 6 to 9 weeks' gestation, and fetal loss from 10 weeks' gestation through the remainder of the pregnancy. These distinctions are important because the causes of pregnancy loss vary over gestational ages, with anembryonic losses being more likely to be associated with chromosomal abnormalities, for example. Possible etiologies for recurrent pregnancy loss include uterine anatomic abnormalities, cytogenetic abnormalities in the parents or fetus, single gene disorders, thrombophilic conditions, and immunologic or endocrine factors as well as environmental or infectious agents (summary by Warren and Silver, 2008).

For a discussion of genetic heterogeneity of recurrent pregnancy loss, see RPRGL1 (614389).


Clinical Features

Chaganti and German (1979) reported a family in which infertility due to azoospermia or oligospermia affected 3 men related through their mothers. Testicular tissue obtained from the 46,XY phenotypically male but azoospermic propositus exhibited normal zygotene and pachytene pairing but premature desynapsis, with a reduced chiasma frequency and degeneration of spermatocytes during the first meiotic division. They postulated that a gene for meiotic disturbance, spermatogenic arrest, and azoospermia was segregating in this family, inherited in either an X-linked recessive or sex-limited autosomal dominant fashion.

Soderstrom and Suominen (1980) examined testicular biopsy specimens from 147 men with the clinical diagnosis of azoospermia or oligospermia. Meiotic arrest was found in 27 cases; closer scrutiny of 7 of the specimens showed that the pattern of meiotic arrest commonly varied in the same specimen, with coexisting areas of normal spermatogenesis and meiotic arrest. Because the timing of the arrest was consistently in the late pachytene stage, with condensation of chromatin along the synaptonemal complex, Soderstrom and Suominen (1980) concluded that there might be a genetic cause for the meiotic arrest.

Chaganti et al. (1980) reported 2 nearly azoospermic sibs of a consanguineous marriage; meiotic cells from a testicular biopsy of the 46,XY phenotypically male proband exhibited asynapsis, defective synaptonemal complex formation, chiasma failure, and degeneration of prophase spermatocytes with asynapsis. The meiotic abnormalities and infertility in this family appeared to comprise an autosomal recessive trait.

Cantu et al. (1981) studied three 46,XY phenotypically male, azoospermic brothers in a sibship of 13 from a consanguineous marriage and found a unique pattern of testicular histology with arrest of spermatogenesis at the pachytene stage of primary spermatocytes.

Recurrent Pregnancy Loss 4

Bolor et al. (2009) studied 2 Japanese women, aged 39 and 29 years, with recurrent pregnancy loss. Each had experienced 3 miscarriages between 6 and 10 weeks of gestation, with no liveborns.


Molecular Genetics

Miyamoto et al. (2003) screened for mutations in the SYCP3 (604759) gene in DNA from 19 unrelated azoospermic patients with maturation arrest and 75 normal pregnancy-proven fertile men. In 2 patients they identified a heterozygous 1-bp deletion (643delA; 604759.0001) that resulted in truncation of the C-terminal, coiled-coil-forming region of the protein. The mutant protein showed greatly reduced interaction with the wildtype protein in vitro and interfered with SYCP3 fiber formation in cultured cells. The results suggested that SYCP3 has an essential meiotic function in human spermatogenesis that is compromised by the mutant protein by dominant-negative interference.

Susceptibility to Recurrent Pregnancy Loss

Bolor et al. (2009) analyzed the SYCP3 gene in 26 Japanese women with recurrent pregnancy loss (RPRGL) and identified heterozygosity for a deletion and a point mutation in 2 of the women (604759.0002 and 604759.0003, respectively) that were not found in 150 fertile women. Both mutant proteins were shown to inhibit normal fiber formation of SYCP3 when coexpressed in a heterologous system. This suggested that the heterozygous mutations are likely to form aberrant lateral elements in the synaptonemal complex in a dominant-negative manner, possibly leading to abnormal chromosomal behavior in meiosis I during oogenesis. Bolor et al. (2009) noted that the SYCP3-related phenotype in humans, in which affected males are infertile whereas affected females have recurrent pregnancy loss, is similar to that seen in Sycp3-deficient mice (Yuan et al., 2000; Yuan et al., 2002).


REFERENCES

  1. Bolor, H., Mori, T., Nishiyama, S., Ito, Y., Hosoba, E., Inagaki, H., Kogo, H., Ohye, T., Tsutsumi, M., Kato, T., Tong, M., Nishizawa, H., Pryor-Koishi, K., Kitaoka, E., Sawada, T., Nishiyama, Y., Udagawa, Y., Kurahashi, H. Mutations of the SYCP3 gene in women with recurrent pregnancy loss. Am. J. Hum. Genet. 84: 14-20, 2009. [PubMed: 19110213] [Full Text: https://doi.org/10.1016/j.ajhg.2008.12.002]

  2. Cantu, J. M., Rivas, F., Hernandez-Jauregui, P., Diaz, M., Cortes-Gallegos, V., Vaca, G., Velazquez, A., Ibarra, B. Meiotic arrest at first spermatocyte level: a new inherited infertility disorder. Hum. Genet. 59: 380-385, 1981. [PubMed: 6800930] [Full Text: https://doi.org/10.1007/BF00295476]

  3. Chaganti, R. S. K., German, J. Human male fertility, probably genetically determined, due to defective meiosis and spermatogenic arrest. Am. J. Hum. Genet. 31: 634-641, 1979. [PubMed: 574357]

  4. Chaganti, R. S. K., Jhanwar, S. C., Ehrenbard, L. T., Kourides, I. A., Williams, J. J. Genetically determined asynapsis, spermatogenic degeneration, and infertility in men. Am. J. Hum. Genet. 32: 833-848, 1980. [PubMed: 7446525]

  5. Miyamoto, T., Hasuike, S., Yogev, L., Maduro, M. R., Ishikawa, M., Westphal, H., Lamb, D. J. Azoospermia in patients heterozygous for a mutation in SYCP3. Lancet 362: 1714-1719, 2003. [PubMed: 14643120] [Full Text: https://doi.org/10.1016/S0140-6736(03)14845-3]

  6. Rai, R., Regan, L. Recurrent miscarriage. Lancet 368: 601-611, 2006. [PubMed: 16905025] [Full Text: https://doi.org/10.1016/S0140-6736(06)69204-0]

  7. Soderstrom, K.-O., Suominen, J. Histopathology and ultrastructure of meiotic arrest in human spermatogenesis. Arch. Path. Lab. Med. 104: 476-482, 1980. [PubMed: 6893401]

  8. Warren, J. E., Silver, R. M. Genetics of pregnancy loss. Clin. Obstet. Gynec. 51: 84-95, 2008. [PubMed: 18303502] [Full Text: https://doi.org/10.1097/GRF.0b013e318161719c]

  9. Yuan, L., Liu, J.-G., Hoja, M.-R., Wilbertz, J., Nordqvist, K., Hoog, C. Female germ cell aneuploidy and embryo death in mice lacking the meiosis-specific protein SCP3. Science 296: 1115-1118, 2002. [PubMed: 12004129] [Full Text: https://doi.org/10.1126/science.1070594]

  10. Yuan, L., Liu, J.-G., Zhao, J., Brundell, E., Daneholt, B., Hoog, C. The murine SCP3 gene is required for synaptonemal complex assembly, chromosome synapsis, and male fertility. Molec. Cell 5: 73-83, 2000. [PubMed: 10678170] [Full Text: https://doi.org/10.1016/s1097-2765(00)80404-9]


Contributors:
Marla J. F. O'Neill - updated : 2/12/2016
Marla J. F. O'Neill - updated : 12/15/2011
Marla J. F. O'Neill - updated : 5/11/2011
John A. Phillips, III - updated : 8/2/2005
Marla J. F. O'Neill - updated : 3/10/2004

Creation Date:
Victor A. McKusick : 6/4/1986

Edit History:
alopez : 06/04/2024
carol : 08/30/2017
carol : 05/12/2016
carol : 2/12/2016
alopez : 12/16/2011
terry : 12/15/2011
terry : 12/9/2011
carol : 5/11/2011
terry : 9/9/2010
alopez : 8/2/2005
carol : 12/14/2004
carol : 3/10/2004
mimadm : 3/12/1994
supermim : 3/17/1992
supermim : 3/20/1990
ddp : 10/27/1989
marie : 3/25/1988
reenie : 6/4/1986